Evidence map›Paper›PMID 41949519›Full record

ArticleJournal of the American College of Cardiology2026

Early Prediction of Heart Failure From Routine Cardiac CT Using Radiomic Phenotyping of Epicardial Fat.

Evangelos K Oikonomou, Kenneth Chan, Parijat Patel, Elizabeth Wahome, Katerina Dangas, Rohan Desai, Ikboljon Sobirov, Rohan Khera, Steffen E Petersen, Francesca Pugliese and 23 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of the American College of Cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Evangelos K OikonomouSection of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
Kenneth ChanDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
Parijat PatelDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
Elizabeth WahomeDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
Katerina DangasDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
Rohan DesaiDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
Ikboljon SobirovDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
Rohan KheraSection of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Steffen E PetersenBarts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Francesca PuglieseBarts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Ronak RajaniDepartment of Cardiology, Guys and St Thomas' Hospital, London, United Kingdom.
Edward NicolRoyal Brompton and Harefield Hospitals, London, United Kingdom; School of Biomedical Engineering and Imaging Sciences, King's College, London, United Kingdom.
Attila KardosDepartment of Cardiology, Translational Cardiovascular Research Group, Milton Keynes University Hospital NHS Foundation Trust, Milton Keynes, United Kingdom.
David AdlamDepartment of Cardiovascular Sciences, University of Leicester and NIHR Leicester Biomedical Research Centre, Leicester, United Kingdom.
Andrew D KelionOxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, United Kingdom.
Nikant SabharwalOxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, United Kingdom.
Nicholas ScreatonRoyal Papworth Hospital, Cambridge, United Kingdom.
John P GreenwoodBaker Heart and Diabetes Institute, Melbourne, Victoria, Australia; Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
Jonathan RodriguesRoyal United Hospital Bath NHS Foundation Trust, Bath, United Kingdom.
Daniel HuckDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Cheerag ShirodariaOxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, United Kingdom; Caristo Diagnostics, Oxford, United Kingdom.
Pete TomlinsDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom; Caristo Diagnostics, Oxford, United Kingdom.
Muhammad SiddiqueDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom; Caristo Diagnostics, Oxford, United Kingdom.
Yogesh SohanDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom; Caristo Diagnostics, Oxford, United Kingdom.
Sam FryCaristo Diagnostics, Oxford, United Kingdom.
Marly van AssenDepartment of Radiology and Imaging Sciences, Emory University Hospital, Atlanta, Georgia, USA.
Ron BlanksteinDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Milind Y DesaiCleveland Clinic Heart and Vascular Institute, Cleveland, Ohio, USA.
Stefan NeubauerDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
Keith M ChannonDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
John DeanfieldInstitute of Cardiovascular Science, University College London, London, United Kingdom.
Charalambos AntoniadesDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom. Electronic address: charalambos.antoniades@cardiov.ox.ac.uk.
ORFAN Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEpicardial adipose tissue (EAT) is a metabolically active visceral fat depot that is both a sensor and a modulator of myocardial biology and changes its composition in response to paracrine signals from the myocardium. We hypothesized that radiomic characterization of EAT from routine coronary computed tomographic angiography (CCTA) can noninvasively capture this adverse remodeling and enable early heart failure (HF) risk stratification.

objectivesWe sought to develop and externally validate a reproducible radiomic signature of EAT associated with incident HF.

methodsWe conducted a multicenter cohort study of 72,751 adults without known HF or myocardial infarction undergoing CCTA across 9 UK centers (2007-2022). We deployed a fully automated pipeline to segment EAT and extract 1,655 volumetric, shape, and higher-order radiomic texture features. Using a harmonized survival autoencoder architecture, we derived the fat radiomic profile for HF (FRP

resultsOver a median follow-up of 5.1 and 4.0 years, 1,737 (2.9%) and 363 (2.7%) participants developed HF in the internal and external validation cohorts, respectively. FRP

conclusionsAutomated radiomic phenotyping of EAT from routine CCTA enables scalable, biologically informed stratification of future HF risk before clinical onset, positioning opportunistic imaging-based visceral fat profiling as a potential tool for precision prevention.

Indexed as

Computed Tomography AngiographyEpicardial Adipose TissueHeart FailureAgedCohort StudiesCoronary AngiographyFemaleHumansMaleMiddle AgedPhenotypePredictive Value of TestsRadiomicsRisk AssessmentTomography, X-Ray Computedartificial intelligencecardiac computed tomographyepicardial adipose tissueheart failureobesityradiomics

Identifiers

PMID41949519
PMCPMC13289806

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.